Ganetespib and HSP90: translating preclinical hypotheses into clinical promise
Semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in rodents [3]
There are a couple of differences between Semaglutide and Liraglutide, the main one being that Semaglutide is a longer-acting medicine, meaning that it can be injected once a week instead of once a day
However, severe or persistent reflux, vomiting, difficulty swallowing, or chest pain warrant immediate medical attention and possible temporary discontinuation of the medication
Semaglutide is a prescription medication in a class called GLP-1 receptor agonists
Overall, the analysis showed that stopping the drugs doesn't lead to significant weight regain, mainly because many patients tend to restart the original medication or try an alternative obesity treatment